Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder

Clinical trial NCT05463822 · COMPLETED

Trial details

NCT number: NCT05463822
Sponsor: Stanford University
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Overactive Bladder Bladder, Overactive Urge Incontinence Urgency Urinary Urinary Frequency/Urgency

Start date: 2019-06-20
Primary completion: 2021-09-27
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.